US 6,207,799 B1 · Neuropeptide Y receptor Y5 and nucleic acid sequences

Abstract

The present invention provides novel NPY/PYY receptor proteins and the nucleic acid sequence encoding them. The invention is directed to the isolation, characterization, and pharmacological use of these receptors and nucleic acids. In particular, this invention provides human and rat NPY/PYY receptors (which we call the NPY Y5 receptor) and nucleic acids. Also provided are recombinant expression constructs useful for transfecting cells and expressing the protein in vitro and in vivo. The invention further provides methods for detecting expression levels of the protein as well as methods for screening for receptor antagonists and agonists to be used for the treatment of obesity or anorexia, respectively.

Claims2

Dependent claims

An isolated neuropeptide Y receptor consisting essentially of the protein encoded by the nucleic acid that hybridizes to the complement of nucleotides 486-861 of SEQ ID NO:

1 under the following hybridization conditions:
hybridization in buffer containing 6×SSC, 0.1% N-lauroylsarcosine, 0.02% sodium dodecyl sulfate, 3% blocking reagent, and 30% formamide at 37° C. and washing with 0.1×SSC and 0.1% sodium dodecyl sulfate at 37° C., wherein the protein consists of 445 amino acids.

Dependencies are inferred from the claim text.

Facts

Application

09/235,839Filed 22 Jan 1999 · continuation

Priority

8 Apr 1996

Granted

27 Mar 2001

Term ends

Not estimatedThe source records don’t support an estimate.

Classification14 codes

G01N 33/6893
Involving proteins, peptides or amino acids: related to diseases not provided for elsewhere
A61K 38/1709
From vertebrates: from mammals
A61P 3/00
Drugs for disorders of the metabolism
A61P 3/04
Drugs for disorders of the metabolism: anorexiants; Antiobesity agents

Neuropeptide Y receptor Y5 and nucleic acid sequences

Life of this patent

Neuropeptide Y receptor Y5 and nucleic acid sequences

Life of this patent

Abstract

Claims2